Savara Inc. (SVRA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$5.10+$0.0300 (+0.59%) on the dayAs of the close; data may be delayed.
SVRA price, last 12 months
Key stats
- Previous close
- $5.07
- Open
- $5.08
- Day range
- $4.87 – $5.18
- 52-week range
- $3.34 – $7.01
- Volume
- 2.3M
- Avg volume (20 days)
- 1.5M
- Market cap
- $1.0B
Performance
1W−5.0%
1M−9.1%
3M−13.6%
6M−2.9%
YTD−15.4%
1Y+45.3%
vs S&P 500, 1Y+28.5 pts
Technicals and fundamentals
About Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.0B